Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

CalciMedica Inc

CALC ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: BUY

Last Close

$1.98

▼ -1.00%

Market Cap $13.52M · Vol 8.52K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$13.52M

Micro Cap

Div Yield

N/A

EPS Growth

+76.01%

YoY

RSI (14)

25.38

Momentum

Beta

N/A

vs Market

52W High

$35.75

94.46% below

52W Low

$1.88

5.60% above

Volume

8.52K

Avg 12.85K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

81.43%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, CalciMedica Inc (CALC) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CALC pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.98%

-41.34%

-54.48%

-52.29%

YTD

-93.99%

-86.11%

-87.63%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-29,562,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-177.10% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	+76.01%
Outstanding Shares	6.83M

Technical Indicators

50-Day SMA	$3.24
200-Day SMA	$8.14
RSI (14)	25.38
Beta	N/A
52-Week High	$35.75
52-Week Low	$1.88

Volume Today	8.52K
Avg Daily Volume (30D)	12.85K
Relative Volume	0.66x
Volatility (10D)	101.60
Volatility (30D)	99.06
Free Float	81.43%

Analyst Consensus

BUY

Current Price $1.98

Mean Target $37.50

52W Low$1.88 52W High$35.75

Current

Target

$1.88 $35.75

Current Analyst target

+1,793.94% upside potential · 4 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG0088HHJB4

ISINUS38942Q3011

CountryUSA

Sub-IndustryBio Therapeutic Drugs

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SER Serina Therapeutics, Inc. -4.08% BYSI Beyondspring Inc -1.25% OGEN Oragenics Inc -2.28% BCDA BioCardia Inc +3.36% CVM CEL-SCI Corp -2.63%

Company Profile

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for inflammatory and immunologic diseases. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase IIb trial (called CARPO) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase I/II asparaginase-induced pancreatic toxicity (AIPT) study (called CRSPA).